Diabetes Treatment
Diabetes mellitus is a chronic metabolic condition with elevated blood glucose. Treatment depends on type and is selected by a clinician — it may include lifestyle changes, oral antidiabetics, GLP-1 receptor agonists or insulin therapy.
Overview
Diabetes mellitus is a group of metabolic disorders characterised by chronically raised blood glucose. Type 1 diabetes is an autoimmune condition with little or no endogenous insulin production. Type 2 diabetes is far more common and develops when insulin resistance and progressive beta-cell decline lead to hyperglycaemia. According to international epidemiological surveys, more than 500 million adults are estimated to live with diabetes worldwide. Untreated, the condition increases the risk of cardiovascular disease, kidney impairment, retinopathy and neuropathy.
Common treatments
First-line pharmacological therapy for type 2 diabetes typically includes metformin, with intensification through GLP-1 receptor agonists, DPP-4 inhibitors, SGLT2 inhibitors or insulin depending on glycaemic targets and comorbidities. GLP-1 receptor agonists such as semaglutide, dulaglutide, liraglutide and the dual GIP/GLP-1 agonist tirzepatide are increasingly used in patients with cardiovascular risk or obesity. Type 1 diabetes always requires insulin replacement, with basal analogues such as insulin glargine combined with prandial insulin. Lifestyle measures — diet, physical activity, weight management — remain a cornerstone of every treatment plan.
When to consult
A medical evaluation is required at diagnosis and at every change in regimen. Persistent hyperglycaemia, episodes of severe hypoglycaemia, unexplained weight loss, recurrent infections or signs of dehydration warrant prompt consultation. According to clinical guidelines, glycated haemoglobin (HbA1c), kidney function and cardiovascular risk should be reassessed periodically. Self-medication with online products is discouraged because it bypasses this assessment and may lead to dangerous interactions or suboptimal control.
Medications
Frequently asked questions
What is the difference between type 1 and type 2 diabetes? ▾
Type 1 diabetes is an autoimmune condition that destroys insulin-producing beta cells; people affected need lifelong insulin therapy. Type 2 diabetes is driven by insulin resistance and progressive beta-cell decline, often in the context of overweight, age and family history. Treatment differs accordingly: type 1 requires insulin from diagnosis, whereas type 2 usually starts with lifestyle measures and oral or injectable non-insulin therapies. Diagnosis is made by a clinician based on glucose, HbA1c and clinical context.
What are GLP-1 receptor agonists? ▾
GLP-1 receptor agonists are injectable or oral medications that mimic the action of glucagon-like peptide 1, a gut hormone that stimulates insulin secretion in response to food, slows gastric emptying and reduces appetite. Examples include semaglutide, dulaglutide and liraglutide; tirzepatide acts on both GLP-1 and GIP receptors. According to international guidelines, this class is recommended in adults with type 2 diabetes who have established cardiovascular disease or in whom additional weight reduction is desirable.
Is insulin only for type 1 diabetes? ▾
No. Insulin is mandatory in type 1 diabetes, but it is also used in type 2 diabetes when oral or injectable non-insulin therapies are insufficient or contraindicated, in pregnancy, in advanced kidney disease and in acute illness. Modern basal analogues such as insulin glargine provide a relatively flat 24-hour profile, often combined with a rapid-acting insulin at meals. Initiation and dose adjustment are always supervised by a clinician.
Can diabetes medication cause weight loss? ▾
GLP-1 receptor agonists and the dual agonist tirzepatide are associated with clinically meaningful weight reduction in many adults, which is one reason they are also approved for chronic weight management under different brand names. Metformin tends to be weight-neutral or to produce mild loss; SGLT2 inhibitors lead to modest weight reduction. In contrast, sulfonylureas and insulin commonly increase weight. The choice of agent should reflect glycaemic and metabolic goals defined by the prescriber.
Is it safe to buy diabetes medication online? ▾
Diabetes medication is prescription-only in most jurisdictions, and buying from unverified online sources carries documented risks including counterfeit products, incorrect strengths and absence of medical supervision. Insulin and GLP-1 agonists are particularly sensitive to storage and cold-chain integrity. Regulatory agencies recommend purchasing only from licensed pharmacies and only after evaluation by a qualified clinician. Reference pages such as this one are intended for information, not for replacing that consultation.
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.